Group 1: Financial Performance - The main reason for the quarter-on-quarter growth in Q3 2025 is the decrease in raw material prices and international shipping costs, along with increased sales [2] - There is a risk of raw material prices rebounding due to international political and economic conditions, trade policies, and market supply-demand relationships [2][3] - The international shipping costs have shown fluctuations in Q3 2025, with potential risks of price increases in the future [3] Group 2: Production Capacity and Expansion - The Malaysian factory has a designed capacity of 60,000 tons per year and is expected to be completed and operational by Q4 2025 [4] - The Polish factory experienced losses in the first half of 2025, but it is a strategic investment for long-term development and gaining customer trust in Europe [5] - The company plans to optimize production across its global factories to meet European demand while considering geopolitical factors [5] Group 3: Industry Growth Prospects - The market for medical hot melt adhesives is stable, with annual growth driven by increasing demand from various demographics, including the elderly and pets [6][7] - Emerging markets present significant growth potential due to low penetration rates despite large populations [7] - The company aims to expand its market share in the medical hot melt adhesive sector while exploring other application areas to create new growth opportunities [7]
聚胶股份(301283) - 2025年10月31日投资者关系活动记录表